Sign In
Buy COR
$263.64
-1.20 (-0.453%)
At Close: Jun 03, 2026
Cencora: Continued Economic Value On The Table Across All Investment Horizons
07:05am, Thursday, 04'th Jan 2024
We have increased our price objective on Cencora to $226/share for the next 6-12 months. The company has exhibited continued earnings growth with minimal capital recycling and strategic use of leverag
Cencora (COR) Hits 52-Week High: What's Aiding the Stock?
12:01pm, Wednesday, 03'rd Jan 2024
Investors are optimistic about Cencora's (COR) strength in the U.S. Healthcare Solutions business.
Reasons to Retain Cencora (COR) Stock in Your Portfolio for Now
08:16am, Friday, 22'nd Dec 2023
Cencora (COR) continues to gain traction from the robust U.S. Healthcare Solutions segment. However, stiff competition is a woe.
Why Cencora (COR) is a Top Growth Stock for the Long-Term
11:16am, Monday, 18'th Dec 2023
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
5 Broker-Favorite Stocks to Keep an Eye on as 2024 Approaches
09:01am, Monday, 18'th Dec 2023
We believe that stocks like American Airlines (AAL), ABM Industries (ABM), Cardinal Health (CAH), Cleveland-Cliffs (CLF) and Cencora (COR) should be on an investor's watchlist.
Cencora (COR) is a Top-Ranked Value Stock: Should You Buy?
11:21am, Thursday, 14'th Dec 2023
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
This 1 Surprising New Tailwind Is Lifting These 2 Evergreen Stocks
10:23am, Monday, 04'th Dec 2023
Medical distributors are seeing increased demand for certain medicines. Drugs for weight loss made by Novo Nordisk and Eli Lilly are what's driving growth.
Cencora (COR) Hits 52-Week High: What's Aiding the Stock?
12:47pm, Monday, 27'th Nov 2023
Investors are optimistic about Cencora's (COR) strength in the U.S. Healthcare Solutions business.
Reasons to Retain Cencora (COR) Stock in Your Portfolio for Now
07:31am, Friday, 24'th Nov 2023
Cencora (COR) continues to gain traction from the robust U.S. Healthcare Solutions segment. However, stiff competition is a woe.
Here's Why Cencora (COR) is a Strong Value Stock
11:18am, Wednesday, 22'nd Nov 2023
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Are Medical Stocks Lagging Cencora, Inc. (COR) This Year?
11:18am, Wednesday, 22'nd Nov 2023
Here is how Cencora (COR) and Amphastar Pharmaceuticals (AMPH) have performed compared to their sector so far this year.
3 Biotech Stocks You'll Regret Not Buying Soon: November 2023
04:17pm, Tuesday, 14'th Nov 2023
Biotechnology is a booming industry recently focused on synthetic biology, biomanufacturing and gene editing. Biotech is seen as the key to the future, as it has the potential to cure diseases and sav
Walgreens sells shares of drug distributor Cencora
07:24pm, Thursday, 09'th Nov 2023
Drugstore chain Walgreens Boots Alliance Inc. WBA, -2.62% on Thursday said it had sold shares of drug distributor Cencora Inc. COR, +0.02% for approximately $424 million. Walgreens also entered into a
Judge trims US lawsuit accusing Cencora of fueling opioid epidemic
05:44pm, Monday, 06'th Nov 2023
A federal judge on Monday pared back a U.S. government lawsuit accusing drug distributor Cencora , formerly called AmerisourceBergen, of fueling the nation's deadly opioid epidemic by failing to repor
Why Cencora (COR) is a Top Value Stock for the Long-Term
11:18am, Monday, 06'th Nov 2023
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
